Vir Biotechnology Inc (VIR) — Cash Flow Quality Index
Latest as of September 2022:
0.67x
Vir Biotechnology Inc (VIR) has a Cash Flow Quality Index of 0.67x as of September 2022. Operating cash flow of $117.90 Million is below net income of $175.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VIR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.67x
Operating CF / Net Income
Operating Cash Flow
$117.90 Million
USD
Net Income
$175.31 Million
USD
Data as of
Sep 2022
Most recent filing
Vir Biotechnology Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Vir Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see VIR cash flow metrics.
Annual Cash Flow Quality Index for Vir Biotechnology Inc (2021–2022)
Year-by-year earnings quality comparison for Vir Biotechnology Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.22x | $1.66 Billion | $515.84 Million | ▲ +3681.4% |
| 2021 | -0.09x | $-47.59 Million | $528.58 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.